1. Home
  2. VTR vs IQV Comparison

VTR vs IQV Comparison

Compare VTR & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventas Inc.

VTR

Ventas Inc.

HOLD

Current Price

$86.35

Market Cap

41.1B

Sector

Real Estate

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$171.94

Market Cap

41.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTR
IQV
Founded
1983
1982
Country
United States
United States
Employees
N/A
93000
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.1B
41.3B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
VTR
IQV
Price
$86.35
$171.94
Analyst Decision
Buy
Buy
Analyst Count
13
15
Target Price
$83.31
$233.33
AVG Volume (30 Days)
2.8M
3.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.40%
N/A
EPS Growth
184.21
4.67
EPS
0.54
7.84
Revenue
$5,833,980,000.00
$9,739,000,000.00
Revenue This Year
$11.61
$6.77
Revenue Next Year
$8.24
$5.91
P/E Ratio
$160.93
$22.29
Revenue Growth
18.47
41.60
52 Week Low
$60.15
$134.65
52 Week High
$87.87
$247.05

Technical Indicators

Market Signals
Indicator
VTR
IQV
Relative Strength Index (RSI) 71.26 38.38
Support Level $66.18 $156.43
Resistance Level $87.24 $193.26
Average True Range (ATR) 1.45 7.54
MACD -0.06 2.08
Stochastic Oscillator 63.22 54.05

Price Performance

Historical Comparison
VTR
IQV

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: